exam 5 - opportunistic infections HIV Flashcards
Drug of choice for MAC treatment
Clarithro 500mg PO BID or Azith 500-600mg PO QD+ Ethambutol 15mg/kg po QD
if MAC is severe what 3rd drug can be added on to treatment
Add rifabutin 300mg PO QD
if MAC is severe what 4th drug can be added on to treatment
levo 500mg PO QD or moxi 400mg PO QD or
amikacin 10-15mg/kg IV daily or streptomycin 1gm IV or IM daily
PJP treatment drug of choice
TMP-SMX 15-20mg/kg/day of TMP IV divided q6-8h x21 days (may switch to PO after clinical improvement)
PJP treatment alternative drug therapy options
-Primaquine 30mg PO QD + Clindamycin (600mg IV q6, 900mg IV q8, 450mg PO q6, or 600mg PO q8).
-Pentamidine 4mg/kg IV qd infused over >60 min
when can adjunctive treatment be added to PJP
moderate to severe (pO2 < 70)
what is adjunctive treatment for mod-sev PJP
prednisone 40mg PO BID x5 days then 40mg PO QD x5 days, then 20mg QD x11 days
(give methylprednisolone 80% if IV)
toxoplasmosis acute infection treatment drug of choice
pyrimethamine 200mg PO x1 followed by weight based dosing
what is the weight based dosing of pyrimethamine <= 60 kg for TE
pyrimethamine 50mg PO QD + sulfadiazine 1500mg PO q6 + leucovorin 10-25mg PO QD
what is the weight based dosing of pyrimethamine > 60kg for TE
pyrimethamine 75mg PO qd + sulfadiazine 1500mg PO q6 + leucovorin 10-25mg PO QD
what is the alternative weight based dosing option for TE acute infection
TMP-SMX 5mg/kg (IV or PO) BID
what is the duration of treatment for TE acute infection
at least 6 weeks, longer may be needed
what are the alternative therapies for TE acute infection
pyrimethamine + leucovorin + clindamycin 600mg IV or PO q6
atovaquone 1500mg PO BID + pyrim + leuco
atovaquone 1500mg PO BID + sulfa
atovaquone 1500mg PO BID
do you do prophylaxis for MAC
yes primary and secondary are both recommended
primary prophylaxis drug of choice for MAC
Azithromycin 1200mg PO once weekly
secondary prophylaxis drug of choice for MAC
Clarithro 500mg PO BID + Ethambutol 15mg/kg PO daily w/wo Rifabutin 300mg PO QD
when to stop primary prophylaxis for MAC
once on a fully suppressive ART regimen
when to restart primary prophylaxis of MAC
CD4 < 50 and not on fully suppressive ART
when to stop secondary prophylaxis treatment for MAC
completed more than 12 months of therapy and there are no s/sxs and a sustained CD4 count > 100 in response to ART
when to restart secondary prophylaxis for MAC
fully suppressive ART regimen not possible and CD4 count consistently < 100
when to start primary prophylaxis for PJP
CD4 100-200 and RNA above limit or
CD4 < 100
prophylaxis drug of choice for PJP
TMP-SMX DS PO QD
TMP-SMX SS PO QD
prophylaxis alternative choice for PJP
TMP-SMX DS PO MWF
Dapsone 100mg PO QD
Atovaquone 1500mg PO QD w/ food
Aerosolized or IV pentamidine 300mg/mouth
when to stop primary and secondary prophylaxis for PJP
-CD4 >200 for >3 months in response to ART
-CD4 100-200 and RNA below limit for 3-6 months